​

Xencor (XNCR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Xencor Revenue Highlights

0

Latest Revenue (Q)

$43.61M

Main Segment (Y)

Milestone

Main Geography (Y)

U

Xencor Revenue by Period

Xencor Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$168.34M2.28%
2022-12-31$164.58M-40.18%
2021-12-31$275.11M124.23%
2020-12-31$122.69M-21.70%
2019-12-31$156.70M285.93%
2018-12-31$40.60M13.70%
2017-12-31$35.71M-59.20%
2016-12-31$87.52M215.25%
2015-12-31$27.76M191.62%
2014-12-31$9.52M-6.41%
2013-12-31$10.17M6.80%
2012-12-31$9.52M39.06%
2011-12-31$6.85M-

Xencor generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Xencor Revenue by Quarter

DateRevenueChange
2025-06-30$43.61M33.23%
2025-03-31$32.73M-53.25%
2024-12-31$70.02M293.45%
2024-09-30$17.80M4.93%
2024-06-30$16.96M6.02%
2024-03-31$16.00M-68.61%
2023-12-31$50.97M-13.86%
2023-09-30$59.16M29.97%
2023-06-30$45.52M140.07%
2023-03-31$18.96M-12.25%
2022-12-31$21.61M-20.84%
2022-09-30$27.30M-9.53%
2022-06-30$30.18M-64.71%
2022-03-31$85.50M-44.49%
2021-12-31$154.02M682.48%
2021-09-30$19.68M-70.82%
2021-06-30$67.45M98.58%
2021-03-31$33.97M-18.85%
2020-12-31$41.85M18.35%
2020-09-30$35.37M170.20%
2020-06-30$13.09M-59.58%
2020-03-31$32.38M821.08%
2019-12-31$3.52M-83.84%
2019-09-30$21.76M11.68%
2019-06-30$19.48M-82.59%
2019-03-31$111.94M868.00%
2018-12-31$11.56M-60.18%
2018-09-30$29.04M100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$10.94M54.32%
2017-09-30$7.09M-46.85%
2017-06-30$13.34M207.37%
2017-03-31$4.34M-32.61%
2016-12-31$6.44M-17.66%
2016-09-30$7.82M-88.15%
2016-06-30$66.01M810.19%
2016-03-31$7.25M-66.66%
2015-12-31$21.75M521.01%
2015-09-30$3.50M245.46%
2015-06-30$1.01M-31.99%
2015-03-31$1.49M-73.68%
2014-12-31$5.66M567.92%
2014-09-30$848.00K2.91%
2014-06-30$824.00K-62.27%
2014-03-31$2.18M25.23%
2013-12-31$1.74M-44.85%
2013-09-30$3.16M-19.36%
2013-06-30$3.92M191.52%
2013-03-31$1.34M-44.54%
2012-12-31$2.42M53.87%
2012-09-30$1.58M-

Xencor generated $43.61M in revenue during Q2 2025, up 33.23% compared to the previous quarter, and up 272.60% compared to the same period a year ago.

Xencor Revenue Breakdown

Xencor Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Milestone$34.50M$88.50M$5.50M$21.00M$50.20M
License$8.50M--$50.20M-
Royalty$600.00K$49.50M$152.10M$17.80M-
Research collaboration-$30.30M$7.00M$93.00M-
Royalties---$80.30M-
Licensing---$80.80M-
Collaboration----$4.50M

Xencor's latest annual revenue breakdown by segment (product or service), as of Dec 24: Milestone (79.13%), License (19.50%), and Royalty (1.38%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Royalty$21.00M$18.61M$18.23M-$7.90M$14.50M$13.30M$13.80M$16.20M$13.40M$7.30M$6.70M$6.10M$4.50M------
Milestone-$25.00M$14.50M$34.00M$500.00K$27.50M$46.00M$10.00M$5.00M$500.00K--$5.00M$7.00M-$1.50M$12.50M$12.40M$25.00M-
Non-cash Royalty----$10.70M$12.30M--------------
Research collaboration------$9.20M$-1.30M$22.20M$200.00K$4.90M$100.00K$200.00K$1.80M$13.30M$6.30M----
Royalties-----------$27.20M$30.00M$78.70M$52.90M-----
Collaboration----------------$58.60M$14.80M$1.30M$900.00K
License------------------$22.10M$5.00M

Xencor's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Royalty (100.00%).

Xencor Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 20Dec 19Dec 18
U$64.10M$142.70M$40.60M
Non United States$58.60M$14.00M-

Xencor's latest annual revenue breakdown by geography, as of Dec 20: U (52.24%), and Non United States (47.76%).

Xencor Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
NKTRNektar Therapeutics$98.43M$11.79M
ANABAnaptysBio$91.28M$76.32M
URGNUroGen Pharma$90.40M$27.48M
PHATPhathom Pharmaceuticals$55.25M$49.50M
NRIXNurix Therapeutics$54.55M$7.89M
TNGXTango Therapeutics$42.07M$53.81M
OCSOculis$883.00K-
KODKodiak Sciences--
BBOTBridgeBio Oncology Therapeutics--
XNCRXencor-$43.61M
MNMDMind Medicine (MindMed)--

XNCR Revenue FAQ

What is Xencor’s yearly revenue?

Xencor's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $168.34M, representing an increase of 2.28% compared to 2022. XNCR's yearly revenue for 2022 was $164.58M, representing a decrease of -40.18% compared to 2021.

What is Xencor’s quarterly revenue?

Xencor's quarterly revenue for Q2 2025 was $43.61M, a 33.23% increase from the previous quarter (Q1 2025), and a 157.12% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $32.73M, a -53.25% decrease from the previous quarter (Q4 2024), and a 104.61% increase year-over-year (Q1 2024). XNCR's quarterly revenue for Q4 2024 was $70.02M, a 293.45% increase from the previous quarter (Q3 2024), and a 37.38% increase year-over-year (Q4 2023).

What is Xencor’s revenue growth rate?

Xencor's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Xencor’s revenue streams?

Xencor's revenue streams in c 24 are Milestone, License, and Royalty. Milestone generated $34.5M in revenue, accounting 79.13% of the company's total revenue, down -61.02% year-over-year. License generated $8.5M in revenue, accounting 19.50% of the company's total revenue Royalty generated $600K in revenue, accounting 1.38% of the company's total revenue, down -98.79% year-over-year.

What is Xencor’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Xencor was Milestone. This segment made a revenue of $34.5M, representing 79.13% of the company's total revenue.